Clinical trial Recruiting at 1 site Interventional Ages 18 to 70

Pulsed field versus radiofrequency approaches to change vagal nerve effects during pulmonary vein isolation for paroxysmal AF

Official title: A Prospective Randomized Study for the Evaluation of the Impact of Point-by-Point Pulse Field Ablation on Autonomic Nervous System Modulation in Paroxysmal Atrial Fibrillation

Run by VZW Cardiovascular Research Center Aalst · NCT06647485 · Data updated 2026-11-12

This study tests whether pulsed field ablation, alone or combined with radiofrequency, changes vagal nerve activity during pulmonary vein isolation in people with paroxysmal atrial fibrillation.

More Atrial Fibrillation (AF) trials

Quick facts

Study typeInterventional
Ages18 Years to 70 Years
SexAll
Enrollment105 (estimated)
SponsorVZW Cardiovascular Research Center Aalst
Academic / other
Locations1 site (Aalst, Belgium)
StatusRecruiting
StartedJanuary 29, 2025
Main results expectedJune 2026
Study endsDecember 2026
Registry record updatedJuly 10, 2025
Trial IDNCT06647485 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18–70 with symptomatic paroxysmal atrial fibrillation that terminates within seven days, who are eligible for point-by-point pulmonary vein isolation and can complete follow-up testing.

Probably not a fit

Patients with persistent AF, prior left atrial ablation or cardiac surgery, severe left ventricular dysfunction, intracardiac thrombus, or implanted pacemakers/ICDs (and other listed exclusions) would not be eligible and are unlikely to benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized interventional study compares three point-by-point pulmonary vein isolation approaches: pulsed field (PF) only, a hybrid PF posterior/RF anterior approach, and RF-only as the control. Heart rate variability (HRV) will be used as a surrogate marker of ganglionated plexi and measured before and 24 hours after the procedure, while troponin and S100B biomarkers are sampled before and 20 minutes after ablation. Participants are followed for 12 months with 24-hour Holter ECGs at 3, 6, and 12 months to monitor rhythm outcomes and longer-term autonomic effects. The trial enrolls adults with symptomatic paroxysmal AF suitable for catheter ablation and excludes those with prior left atrial ablation, recent MI, severe LV dysfunction, intracardiac thrombus or implanted cardiac metal devices.

Why it matters

Potential benefit: If successful, the approach could guide ablation strategies that reduce unwanted autonomic effects and improve symptom control for people with paroxysmal AF.

How similar studies have gone: Pulsed field ablation has shown promising safety and efficacy for pulmonary vein isolation in recent studies, but its specific effects on autonomic ganglia and combinations with RF energy are not well established.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Symptomatic Paroxysmal Atrial Fibrillation (AF) that terminates spontaneously or with intervention within 7 days of onset
* Age range: 18-70 years
* Willing and capable of providing informed consent
* Able and willing to comply with all pre-, post-, and follow-up testing and requirements

Exclusion Criteria:

* Previously diagnosed Persistent AF (\> 7 days in duration)
* Previous LA ablation
* Previous cardiac surgery
* Myocardial Infarction within the previous 3 months
* Severely compromised Left Ventricular Ejection Fraction (LVEF\<40%)
* Presence of implanted pacemaker or Implantable Cardioverter-Defibrillator (ICD) or other implanted metal cardiac device that may interfere with the pulsed electric field energy
* Acute illness, active systemic infection, or sepsis
* Presence of intracardiac thrombus, myxoma, tumor, interatrial baffle or patch or other abnormality that precludes catheter introduction or manipulation.
* Severe mitral regurgitation
* Woman who are pregnant, lactating, or who are planning to become pregnant during the course of the clinical investigation

Where it's running

  • OLV Hospital
    Aalst, Belgium, Belgium
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.